-Economic and Political Weekly   Much work remains to be done if the new Land Acquisition, Rehabilitation and Resettlement Act has to mark a meaningful shift for India's adivasi communities. Chitrangada Choudhury (chitrangada@csds.in) Chitrangada Choudhury (chitrangada@csds.in) is a multimedia journalist and researcher, and currently with the Publics and Policies program at the Centre for the Study of Developing Societies, New Delhi. Among the worst excesses committed in India's six decade-old democracy, the forcible displacment...

-The Times of India NEW DELHI: Stung by the recent spate of judgments ushering in a series of electoral reforms, the Centre on Monday told the Supreme Court that judiciary should keep off a plea to bar persons, against whom charges have been framed in serious offences, from contesting polls as the issue fell squarely within the domain of legislature and government's policy arena. "The issue agitated through this petition are policy...

-Live Mint Apex court expresses concerns about drug trials being permitted on humans without comprehensive rules to regulate the approval process New Delhi: The apex court on Monday directed the health ministry to justify its approval for 162 global clinical trials in India, increasing the uncertainty faced by the nation's $500 million clinical research industry. The Supreme Court expressed its concerns about drug trials being permitted on humans without comprehensive rules to...

-The Hindu If the Adani group is allowed to continue its development projects in Kutch simply by ‘compensating' for their ecological damage, the Centre will set a dangerous precedent that lets money power trump environmental regulations The Adani Group may be fined Rs.200 crore for a series of environmental violations committed by their waterfront development, port and power plant projects in the Mundra taluka of Kutch district. The waterfront development project, which...

-The Times of India NEW DELHI: The Supreme Court on Monday forced the Centre to stop clinical trials of 162 new drugs or chemical entities which had been cleared by the expert committee for testing on human beings in India. A bench of Justices R M Lodha and Shiva Kirti Singh was about to pass an order restraining the Centre from going ahead with these clinical trials when additional solicitor general Sidharth...